Cargando…

Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

PURPOSE: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of adult lymphomas. The incidence of DLBCL increases with age and has a fairly rapid fatal course without treatment. Patients often have difficulty tolerating standard chemotherapy regimens due to their comorbidities. Charlson...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eren, Rafet, Serin, Istemi, Atak, Suheyla, Pirdal, Betul Zehra, Nizam, Nihan, Gemici, Aliihsan, Aydın, Demet, Demirel, Naciye, Dogan, Esma Evrim, Yokus, Osman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516503/ https://www.ncbi.nlm.nih.gov/pubmed/36186233 http://dx.doi.org/10.1007/s12288-022-01567-5

Ejemplares similares

The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?
por: Atak, Suheyla, et al.
Publicado: (2023)

How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey
por: Eren, Rafet, et al.
Publicado: (2020)

An Unconventional Presentation of Multiple Myeloma: Bazex Syndrome
por: Kandemir Alibakan, Özlem, et al.
Publicado: (2020)

Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
por: Uğur, Mehmet Can, et al.
Publicado: (2021)

Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?
por: Efe İris, Nur, et al.
Publicado: (2017)

Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
por: Gedik, Habip, et al.
Publicado: (2014)

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014)

Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts
por: Serin, Istemi, et al.
Publicado: (2020)

Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia
por: Yokus, Osman, et al.
Publicado: (2020)

Kimura Disease Associated with Minimal Change Disease
por: Eren, Rafet, et al.
Publicado: (2021)

Analysis of variation in length of stay (LOS) after ischemic and hemorrhagic stroke using the Charlson Comorbidity Index (CCI)
por: Lim, Ji-Hye, et al.
Publicado: (2015)

PB2234: EFFECT OF HYDROXYUREA ON INFLAMMATORY MARKERS IN PATIENTS WITH BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISEASES
por: Altunok, Oguz, et al.
Publicado: (2023)

PB2400: THE EFFECT OF BONE MARROW CD4/CD8+ RATIO ON RESPONSE TO TREATMENT AND SURVIVAL IN LYMPHOMAS
por: Can Cavdar, Vahit, et al.
Publicado: (2023)

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL
por: Yokus, Osman, et al.
Publicado: (2023)

PB2245: POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?
por: Yokus, Osman, et al.
Publicado: (2023)

PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE
por: Karişmaz, Kadir, et al.
Publicado: (2023)

A case report: paroxysmal nocturnal hemoglobinuria and systemic lupus erythematosus association
por: Serin, Istemi, et al.
Publicado: (2020)

PB2237: NON-THROMBOTIC INCREASED PORTAL VENOUS PRESSURE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: IS IT JUST A HYPOTHESIS?
por: Yokus, Osman, et al.
Publicado: (2023)

PB2321: THE EFFECT OF PRE-TREATMENT SERUM KINDLIN-3 ON HODGKIN AND NON-HODGKIN LYMPHOMAS: A SINGLE CENTER EXPERIENCE
por: Keskin, Melike, et al.
Publicado: (2023)

Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment
por: Yokus, Osman, et al.
Publicado: (2022)

Iron overload during the treatment of acute leukemia: pretransplant transfusion experience
por: Yokus, Osman, et al.
Publicado: (2021)

A Huge Mass in the Liver: Plasmacytoma
por: Cinli, Tahir Alper, et al.
Publicado: (2022)

PB1752: SAMATYA-PREDICTING SCORE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): COMBINING CLINICAL FEATURES WITH FLOW CYTOMETRY
por: Cinli, Tahir Alper, et al.
Publicado: (2023)

Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience
por: Serin, Istemi, et al.
Publicado: (2022)

The heat wave knowledge, awareness, practice and behavior scale: Scale development, validation and reliability
por: Sayili, Ugurcan, et al.
Publicado: (2022)

A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement
por: Eren, Rafet, et al.
Publicado: (2016)

The impact of cardiopulmonary exercise testing (CPET) and Charlson comorbidity index (CCI) in a large contemporary cohort of patients undergoing robot‐assisted radical cystectomy and intracorporeal urinary diversion (RARC‐ICUD)
por: McPhee, Arthur, et al.
Publicado: (2022)

Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data
por: Karakus, Volkan, et al.
Publicado: (2022)

A new approach in acute myeloid leukemia (AML): Samatya-predicting score
por: Serin, Istemi, et al.
Publicado: (2022)

COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
por: Kara Esen, Beril, et al.
Publicado: (2021)

Working arrangements of the CCI computer exploitation section:
por: Madsen, Jan H B, et al.
Publicado: (1974)

Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?
por: Comoglu, Senol, et al.
Publicado: (2022)

Metabolomics Analysis of DRG and Serum in the CCI Model of Mice
por: Lu, Kaimei, et al.
Publicado: (2023)

PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
por: Serin, Istemi, et al.
Publicado: (2023)

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
por: Messina, Michael P, et al.
Publicado: (2007)

Combination of Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score
por: Asai, Nobuhiro, et al.
Publicado: (2021)

La cour internationale d'arbitrage de la CCI
por: International Chamber of Commerce. Paris, et al.
Publicado: (1994)

Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
por: Cavuşoğlu Türker, Betül, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0h2bu2qos5e1tpefijcbg7ga2